Results 121 to 130 of about 41,093 (223)

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB₂ in malaria exposed individuals [PDF]

, 2009
Background MB2 protein is a sporozoite surface antigen on the human malaria parasite Plasmodium falciparum. MB2 was identified by screening a P. falciparum sporozoite cDNA expression library using immune sera from a protected donor immunized via the ...
James Anthony A, de la Vega, Patricia, John, Chandy C, Thanh V Nguyen, Nguyen, Thanh V, de la Vega, P, John B Sacci, Patricia de la Vega, James, Anthony A, Kang Angray S, John Chandy C, James, AA, Nguyen, T.V., Sacci, John B, Kang, A.S., Sacci John B, de la Vega, P., Nguyen Thanh V, Anthony A James, de la Vega Patricia, John, C.C., Kang, Angray S, Angray S Kang, Sacci, J.B., Patricia Vega, Chandy C John, John, CC, Nguyen, TV, Kang, AS, Jr, SJB, James, A.A.   +30 more
core   +1 more source

First Malaria Vaccine RTS, S: A Step toward the Eradication of Malaria [PDF]

Archives of Razi Institute
Malaria is a mosquito-borne life-threatening illness caused by the parasites, Plasmodium. Around 50% of the world’s population is at danger of this infectious disease. Antimalarial drug-Artemisinin, extracted from the plant Artemisia annua and has become
Amit Bhattacharya, Neetu Bhattacharya
doaj   +1 more source

Understanding Opportunity Costs of Women Participating in Maternal and Child Nutrition Interventions in Southern Angola: Evidence From the MuCCUA Trial

Maternal &Child Nutrition, Volume 22, Issue 3, July 2026.
Economic evaluations of multisectoral nutrition interventions often overlook participants' costs. Using MuCCUA trial data, we estimated women's opportunity costs of three maternal and child nutrition interventions in Angola. Remote participants faced burdens equivalent to 1–1.5 workdays monthly.
Rocio Martin‐Cañavate, Antonio Pujol‐de Castro, Chloe Puett, Elena Trigo, Maria de Lourdes Faria, Ana Silva Gerardo, Antonio Vargas, Israel Molina, Estefania Custodio   +8 more
wiley   +1 more source

Application of mathematical modeling for malaria control decision-making in settings of varying transmission intensity [PDF]

, 2015
Planning for the control of Plasmodium falciparum malaria at the population level demands models of malaria epidemiology that provide realistic quantitative prediction of likely epidemiological outcomes of a wide range of control strategies. This project
Stuckey, Erin Mae
core   +1 more source

Routine malaria vaccination in Africa: a step toward malaria eradication?

Malaria Journal
Malaria remains a significant global health challenge, with nearly half of the world's population at risk of infection. In 2022 alone, malaria claimed approximately 608,000 lives, with 76% of these fatalities occurring in children under the age of five ...
Olivier Sibomana, John Bukuru, Sulymon A. Saka, Marie Grace Uwizeyimana, Alex Mwangi Kihunyu, Abraham Obianke, Samuel Oluwo Damilare, Lewis Tem Bueh, Beloved of God Agbelemoge, Richard Omoefe Oveh   +9 more
doaj   +1 more source

Recent advances on vaccines against malaria: A review

Asian Pacific Journal of Tropical Medicine
This review aims to summarize the currently viable vaccine strategies including the approved vaccines and the those in trials for next-generation malaria vaccines. Data on malaria vaccine development was collected through a comprehensive review.
Shiza Malik, Yasir Waheed
doaj   +1 more source

Combining Treatment of Acute Malnutrition With Integrated Community Case Management: A Cluster‐Randomised Controlled Trial (SETiPlus)

Maternal &Child Nutrition, Volume 22, Issue 3, July 2026.
ABSTRACT Achieving good treatment coverage and outcomes for acutely malnourished children is challenging in resource limited and remote settings. Inclusion of treatment within integrated community case management (iCCM) programmes has shown promise, but evidence is limited. We conducted a cluster randomised controlled trial in rural villages within the
Gael Cronin, Mohamed Jelle, Shukri Ali, Yuusuf Siciid, Yayha Abdillahi, Meftuh Omer, Adan Yusuf Mahdi, Saed Abdi Ibrahim, Lilly Scholfield, Emily Keane, Khalid Ali Ahmed, Andrew Seal   +11 more
wiley   +1 more source

Stochastic simulation models of "Plasmodium falciparum" malaria epidemiology and control [PDF]

, 2008
Every year malaria causes an estimated 1.3–3 million deaths and around half a billion clinical episodes. The majority of deaths occur in children under the age ofyears.
Maire, Nicolas
core   +1 more source

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.

PLoS ONE, 2019
The development of effective malaria vaccines remains a global health priority. Currently, the most advanced vaccine, known as RTS,S, has only shown modest efficacy in clinical trials.
Jo-Anne Chan, David Wetzel, Linda Reiling, Kazutoyo Miura, Damien R Drew, Paul R Gilson, David A Anderson, Jack S Richards, Carole A Long, Manfred Suckow, Volker Jenzelewski, Takafumi Tsuboi, Michelle J Boyle, Michael Piontek, James G Beeson   +14 more
doaj   +1 more source

The EBNA‐1 Conundrum: Does Epstein–Barr Virus Invoke Autoimmune Pathology in a Population Subset by Poorly Purine‐Loading Its Major Latency‐Maintaining Transcript?

Scandinavian Journal of Immunology, Volume 104, Issue 1, July 2026.
ABSTRACT Viruses activate host defences by alerting interferon and other alarms. Viruses seeking latency must curtail this. Infected subjects would then have minimal immune system activation and remain healthy. However, a minority cannot prevent emergence of associated diseases.
Donald R. Forsdyke
wiley   +1 more source